Bit & Bridle

Equine Sporotrichosis

Other Names

  • Sporothrix schenckii infection
  • Rose thorn disease
  • Rose gardener’s disease
  • Lymphocutaneous sporotrichosis

What is Equine Sporotrichosis?

Sporotrichosis is a subacute to chronic fungal infection caused by the dimorphic fungus Sporothrix schenckii and related species within the Sporothrix genus. The organism lives as a saprophyte in soil, decaying vegetation, and organic matter, and infects horses (and other animals, including humans) through direct inoculation via skin wounds — cuts, abrasions, punctures from thorns or wood splinters.

In horses, the condition typically manifests as a cutaneous or lymphocutaneous form, with nodular skin lesions developing along the course of the draining lymphatics — a characteristic pattern known as sporotrichoid spread. The condition is most prevalent in tropical and subtropical regions, though it is reported worldwide. It is considered the most common subcutaneous mycosis in parts of Latin America, where outbreaks associated with feline transmission have been documented. In the UK and temperate climates, equine sporotrichosis is uncommon but does occur sporadically.

Sporotrichosis is also a zoonotic disease — it can be transmitted from infected animals (particularly cats) to humans through bites, scratches, or contact with wound exudate. Appropriate protective measures should be taken when handling affected horses. For related skin conditions in horses, see our entry on Equine Insect Hypersensitivity.

Causes

Infection results from traumatic inoculation of Sporothrix organisms into the skin. The fungus is thermally dimorphic — it exists as a mould (mycelial form) at environmental temperatures and converts to a yeast form at body temperature, where it can evade some host immune defences.

Risk factors for equine sporotrichosis include:

  • Environments with decaying plant matter, compost, or soil rich in organic material
  • Areas with brambles, thorns, or rough vegetation that cause frequent minor skin wounds
  • Marshy, humid environments that favour Sporothrix growth
  • Contact with infected cats or rodents in endemic areas
  • Immunosuppression — horses on corticosteroids or with concurrent systemic illness may be more susceptible

Sporothrix brasiliensis, a more virulent species, is associated with zoonotic outbreaks in Brazil, particularly through infected domestic cats. While rare in the UK, travellers and imported animals from endemic regions should be aware of this species.

Symptoms and Signs

Clinical signs of equine sporotrichosis are characteristic:

  • Initial lesion — a firm, painless nodule at the site of inoculation, most commonly on the lower limbs, face, or body. The nodule may ulcerate, discharging a purulent or serosanguineous exudate.
  • Lymphocutaneous spread — the classic pattern: multiple nodules develop along the course of the draining lymphatics proximal to the primary lesion, giving a chain-like appearance up the limb or body
  • Cord-like thickening of the lymphatic vessels between nodules may be palpable
  • Ulceration and crusting of individual nodules, with periodic discharge
  • Secondary bacterial infection of ulcerated nodules
  • Systemic signs are uncommon in horses with normal immune function, but fever, weight loss, and depression may occur in severe or disseminated cases

The slow, progressive nature of the lesions — developing over weeks to months — is typical. Horse owners often initially attribute the nodules to insect bites, thorn injuries, or minor skin infections before the characteristic pattern becomes apparent.

Diagnosis

Sporotrichosis can be difficult to confirm, as direct microscopic identification of the organism in smears is often unreliable. Definitive diagnosis requires:

  • Fungal culture — swabs or tissue from ulcerated nodules are cultured on appropriate fungal media (Sabouraud’s dextrose agar) at both 25°C and 37°C to demonstrate the dimorphic nature of the organism. Culture may take two to four weeks.
  • Histopathology — tissue biopsy with special stains (PAS, Grocott’s methenamine silver) can reveal the yeast forms within the tissue, though they may be sparse in equine cases
  • Cytology — fine needle aspirate from intact nodules; the cigar-shaped yeast forms may be visible on cytological preparation but are often not numerous
  • PCR — molecular testing is increasingly available and provides rapid, specific diagnosis
  • Latex agglutination serology — available in some reference laboratories; useful as a supportive diagnostic tool

A high index of suspicion in horses with the characteristic lymphocutaneous nodule pattern in an endemic region, combined with appropriate culture, leads to diagnosis in most cases.

Treatment

Treatment requires prolonged antifungal therapy — short courses are insufficient and will result in relapse:

  • Itraconazole — the antifungal of choice for equine sporotrichosis. Administered orally at veterinary-prescribed doses for a minimum of four to six months, or until two months after complete clinical resolution.
  • Potassium iodide — a traditional treatment, orally administered, that is inexpensive and has shown efficacy in lymphocutaneous sporotrichosis. May cause iododerma (iodine toxicity) at higher doses — monitor carefully.
  • Fluconazole — an alternative azole antifungal, though Sporothrix susceptibility varies; not first-line but may be used in resistant cases
  • Amphotericin B — reserved for severe, disseminated, or life-threatening cases; requires IV administration and carries significant nephrotoxicity risk
  • Surgical debridement — in some cases, debridement or excision of individual nodules may be appropriate, but systemic antifungal therapy must accompany any surgical intervention

Treatment response should be monitored clinically, with reassessment at regular intervals. Complete resolution of lesions is the goal before treatment is discontinued.

Prevention

Prevention focuses on reducing the risk of fungal inoculation and recognising early signs:

  • Manage pastures and environments to reduce accumulation of decaying vegetation and organic debris
  • Promptly clean and disinfect any wounds, particularly puncture wounds from thorns, wood, or wire
  • Wear gloves when handling horses with skin nodules or discharging wounds — particularly relevant in endemic areas or where zoonotic species are present
  • Avoid housing horses in direct contact with infected cats in endemic regions
  • Check horses regularly for new skin lesions, particularly on the lower limbs and face

Prognosis

The prognosis for equine sporotrichosis is generally good with early diagnosis and appropriate treatment. Lymphocutaneous disease typically responds well to prolonged antifungal therapy. Disseminated or systemic disease is rare in horses but carries a more guarded prognosis. Recurrence is possible if treatment is discontinued prematurely or if the horse is re-exposed to the organism in an endemic environment.

When to Call the Vet

  • Your horse develops firm nodules on the lower limbs or body, particularly if they are slow to resolve or are associated with limb swelling
  • Multiple nodules appear in a chain-like pattern along a limb — this pattern is highly suggestive of sporotrichosis or a lymphocutaneous infection and requires investigation
  • Nodular lesions are persisting or enlarging despite standard wound care
  • You or anyone handling an affected horse develops skin nodules or wounds that are not healing normally — seek medical advice as zoonotic transmission is possible

Frequently Asked Questions

Can humans catch sporotrichosis from horses?

Yes — sporotrichosis is a zoonotic disease. Transmission occurs through direct contact with fungal organisms in the wound exudate or environment, entering via skin cuts or abrasions. Wearing gloves when handling affected animals and maintaining good hand hygiene significantly reduces the risk. If you develop skin nodules or non-healing wounds after contact with a horse with sporotrichosis, inform your doctor of the exposure history.

How long does treatment take?

Treatment is prolonged — a minimum of four to six months is typically required, and treatment should continue for at least two months after all lesions have resolved. Stopping treatment too early is the most common reason for relapse. This makes compliance important, particularly as horses may appear clinically normal before the infection is fully eradicated.

Is sporotrichosis common in the UK?

No — it is uncommon in the UK and temperate climates compared to tropical and subtropical regions. When it does occur, it is typically in horses exposed to environments with significant organic debris or in imported animals from endemic regions. However, veterinary awareness of the condition is important as it can be easily misdiagnosed as a bacterial skin infection.

What does a sporotrichosis lesion look like on a horse?

Initially, lesions appear as firm, painless nodules ranging from one to three centimetres in diameter. Over time, they may ulcerate, producing a purulent or serosanguineous discharge. The characteristic feature is the linear chain of nodules following the path of lymphatic vessels from the primary lesion. See our equine skin condition terminology for more guidance on assessing horse skin lesions.